Puma Biotechnology (NASDAQ:PBYI – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday. Separately, HC Wainwright reduced their target price on Puma Biotechnology from $8.00 to $7.00 and set a “buy” rating on the stock in a research report […]
HC Wainwright reiterated their buy rating on shares of Puma Biotechnology (NASDAQ:PBYI – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. They currently have a $8.00 price target on the biopharmaceutical company’s stock. Separately, StockNews.com upgraded shares of Puma Biotechnology from a buy rating to a strong-buy rating in a […]
Puma Biotechnology, Inc. (NASDAQ:PBYI – Get Free Report) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $3.52 and traded as high as $5.16. Puma Biotechnology shares last traded at $4.71, with a volume of 749,465 shares trading hands. Wall Street Analyst Weigh In Separately, […]
Puma Biotechnology, Inc. (NASDAQ:PBYI – Get Free Report) CFO Maximo F. Nougues sold 15,682 shares of the stock in a transaction dated Wednesday, January 3rd. The shares were sold at an average price of $4.49, for a total transaction of $70,412.18. Following the completion of the sale, the chief financial officer now owns 128,666 shares […]
StockNews.com upgraded shares of Puma Biotechnology (NASDAQ:PBYI – Free Report) from a buy rating to a strong-buy rating in a research note released on Wednesday morning. Separately, HC Wainwright reissued a buy rating and issued a $8.00 price objective on shares of Puma Biotechnology in a research report on Wednesday, September 20th. Read Our Latest […]